Patents Assigned to Applaud Medical, Inc.
  • Method of treating urolithiasis
    Patent number: 11903954
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: February 20, 2024
    Assignee: APPLAUD MEDICAL, INC.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • System and method for detecting and aligning acoustic beam in situ to a target using wide-beam, low frequency (<1 mhz) ultrasound
    Patent number: 11896253
    Abstract: The present invention is directed to a novel target detecting device comprising an excitation transducer generating a low frequency pulses of weakly focused ultrasonic energy and a sensing transducer. The present invention also includes a method of aligning a treatment transducer to a target by mapping the target in situ by sending a low frequency ultrasound signal and receiving reflected signals from the target. These inventions provide a simpler way of determining the location of a target and aligning a treatment transducer without the need to generate and interpret an image and then translate the image back onto the target.
    Type: Grant
    Filed: February 28, 2022
    Date of Patent: February 13, 2024
    Assignee: Applaud Medical, Inc.
    Inventors: William Behnke-Parks, Daniel Laser
  • Methods of manufacturing microspheres
    Patent number: 11844807
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: December 19, 2023
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • Phospholipid compounds and formulations
    Patent number: 11464792
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: October 11, 2022
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke
  • System and method for detecting and aligning acoustic beam in situ to a target using wide-beam, low frequency (<1 MHz) ultrasound
    Patent number: 11291464
    Abstract: The present invention is directed to a novel target detecting device comprising an excitation transducer generating a low frequency pulses of weakly focused ultrasonic energy and a sensing transducer. The present invention also includes a method of aligning a treatment transducer to a target by mapping the target in situ by sending a low frequency ultrasound signal and receiving reflected signals from the target. These inventions provide a simpler way of determining the location of a target and aligning a treatment transducer without the need to generate and interpret an image and then translate the image back onto the target.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: April 5, 2022
    Assignee: Applaud Medical, Inc.
    Inventors: William Behnke-Parks, Daniel Laser
  • Phospholipid compounds and formulations
    Patent number: 10953023
    Abstract: The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: March 23, 2021
    Assignee: Applaud Medical, Inc.
    Inventors: Daniel J. Laser, Alice Luong, Robert G. Miotke